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Estimates of the impact of apolipoprotein E (apo E) alleles coding for the three 
common isoforms on plasma lipid levels assume genetic homogeneity among the 
genotype classes. To test this assumption, we have determined the apo E genotype 
at the two common polymorphic sites (amino acids 112 and 158) by DNA amplifi- 
cation and hybridisation with allele-specific oligoprobes, in 195 unrelated Cauca- 
sian participants of the Rochester Family Heart Study previously classified as het- 
erozygotes by isoelectric focusing (IEF). Fourteen discordant samples were ini- 
tially detected. Repeat typing of these samples by both methods resolved nine 
discrepancies and analysis of additional blood samples from the remaining five 
individuals eliminated a further four discrepancies. The only truly discordant allele 
was found in a female subject who had an E3 isoform with the common E2 (CYS, ,~ ,  
C Y S ~ ~ ~ )  genotype. Transmission of this allele from the mother was demonstrated. 
From these results, we estimate the frequency of discrepancies between isoforms 
and common genotypes to be 0.25% in this population. Allele misclassification 
was caused by poor amplification of the DNA in six samples and superimposition 
of glycosylated and nonglycosylated apo E isoforms on isoelectric focusing gels in 
five samples. We conclude that the assumption of genetic homogeneity among geno- 
type classes is valid and that misclassification due to technical difficulties is more 
frequent than true discordancies. o 1992 Wiley-Liss, Inc. 
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INTRODUCTION 
Polymorphic allelic variation at the human apolipoprotein E (apo E) locus is known 
to have a significant role in determining interindividual variation in plasma levels of 
apolipoprotein E, apolipoprotein B , total cholesterol, and LDL-cholesterol in the gen- 
eral population [Sing and Davignon, 1985; Davignon et al., 1988; Kaprio et al., 1991; 
Xhignesse et al., 19911. These effects have been replicated in a variety of human pop- 
ulations of diverse genetic background exposed to a variety of cultural and dietary 
environments [Boerwinkle et al., 1987; Sepehrnia et al., 1989al. Apolipoprotein E 
genetic variation can be detected at the protein level using a variety of electrophoretic 
techniques [Utermann et al., 1977; Zannis et al., 1981; Bouthillier et al., 1983; Kamboh 
et al., 19881. Detection at the DNA level can be achieved by amplification of the DNA 
segment containing E2/E3 and E3/E4 allelic substitution sites using the polymerase 
chain reaction (PCR) followed by hybridisation to allele specific oligonucleotides [Funke 
et al., 1986; Emi et al., 1988; Houlston et al., 1989 Smeets et al., 19881 or digestion 
with the restriction endonuclease HhaI to yield allele specific cleavage patterns [Hixson 
and Vernier, 19901. Genetic heterogeneity in the common E2, E3, and E4 phenotypes 
has been recognized in allele products which give a similar or identical isoprotein pat- 
tern as for one of the common alleles. These involve distinct, rare, amino acid substi- 
tutions and are frequently associated with familial hyperlipoproteinaemia. 
The measured genotype approach used in the estimation of allelic effects associ- 
ated with the apo E polymorphism assumes allelic homogeneity within phenotype classes. 
With the exception of the study of Emi et al. [1988], there have been no population- 
based studies to estimate the frequency of discrepancies between the isoforms deter- 
mined by IEF and the genotypes at the apo E locus. In this context, discrepancies refer 
to alleles giving rise to the protein phenotype of one of the common apo E alleles, but 
which contain nucleotide substitutions different than those causing the common poly- 
morphism. We have used a combination of protein typing by IEF-immunoblotting and 
genotyping using the PCR technique followed by hybridization to allele specific oligo- 
nucleotides (ASO) to estimate directly the frequency of discrepant alleles occurring in 
the E2, E3, and E4 isoform classes in a sample of individuals heterozygous for the 
protein polymorphisms and selected from the general population of Rochestr, MN. 
In the course of comparing genotype assignments using these two methods, we have 
identified common sources of error associated with phenotyping and genotyping . The 
results are discussed in the context of application of the measured genotype approach 
to the estimation of allelic effects in population samples. 
MATERIALS AND METHODS 
Sample 
All samples for this study were drawn from the Rochester Family Heart Study 
described by Moll et al. [ 19891 and Turner et al. [ 19891. The Rochester Family Heart 
Study was designed to evaluate the effects of environment and inherited traits on lipid 
transport and hypertension. In Janury 1984, we arranged for officials of the school 
system in Rochester, MN, to send letters to 5,270 households having two or more 
children enrolled in the city’s public and parochial schools. In the letter, we first described 
Apo E: Discrepant Alleles 241 
the purpose of the study and then requested each household willing to consider partici- 
pation in the study to return an enclosed questionnaire providing information about the 
household (number of children in the household, projected future length of residence 
in Rochester, number of grandparents living in the Rochester area), phone number, 
and address. The questionnaire did not contain any queries regarding disease status or 
family history of disease. From a total of 1,812 questionnaires that were returned 
(response rate of 34.4%), 159 households were judged unsuitable for sampling either 
because they (1) did not want to be contacted further (n = 105), (2) reported they 
planned to move from Rochester within 12 months (n = 12), (3) reported there were 
only adopted children in the household (n = 17), or (4) gave various other reasons (n 
= 25) that participation was unlikely (e.g., unwillingness to visit the clinic or have 
blood drawn). Between December 1, 1984 and January 1, 1988 we contacted 436 of 
the 1,653 households eligible for sampling, and 2,004 individuals identified by 300 
households agreed to participate and completed a clinic visit. These 2,004 individuals 
were distributed among 276 pedigrees ranging in size from 1 to 24 (mean 7.3). The 
study reported here is based on 567 unrelated spouses from these pedigrees who were 
parents of the index school children. 
Among the 567 individuals eligible for the present study, 565 were typed for Apo 
E. Three were E2/2, 65 were E3/2, 329 were E3/3, 10 were E4/2, 149 were E4/3, and 
9 were E4/4. Of the 224 heterozygotes, 195 (58 E3/2, 10 E4/2, and 127 E413) had 
both plasma and DNA samples available for the present study and were used to esti- 
mate the frequency of discrepancies. 
LABORATORY METHODS 
Plasma cholesterol, triglyceride, HDL-cholesterol (HDL-C) , and apolipoproteins 
AI, AII, B, CII, CIII, and E levels were measured as described by Kottke et al. [ 19911. 
Apolipoprotein E phenotypes were determined from frozen EDTA plasma by the 
isoelectric focusing-immunoblot method of Kamboh et al. (19881 on samples trans- 
ported on dry-ice. DNA was extracted from peripheral white blood cells by the Triton 
X-100 lysis method [Kunkel et al. 19771 and sent to London on dry-ice for analysis. 
Apo E genotypes were determined by direct amplification of a 330 bp region spanning 
both the E2/E3 and E3/E4 allelic sites (aminio acids 94-203), and detection by 
hybridisation to end-labelled allele-specific oligonucleotides, following transfer to 
Hybond-N filters (Amersham), essentially as described by Houlston et al. [1989]. The 
allele-specific oligoprobes (ASO) were however shortened as follows: Argl 12, 3'- 
CGCGAAGAC-5'; kg158 3 '-CGTCTTCACGGACCG-5'. Hybridisation was carried 
out at 42°C and filters were washed briefly at 49-50°C. In later experiments, a second 
Arg, 12 probe, 3'-GCCGGTGCGTGCAGG-5', containing an additional mismatch at 
the 6th nucleotide from the 3' end (T for C), was used. The discriminant washing tempera- 
tureforthisprobewas53-54"Cin3 X SSPE(1 X SSPE = 0.15MNaC1,0.01MNaH2P04, 
0.001 M EDTA, pH 7.4). 
Genotyping was also carried out by amplification of a 216 bp region, again span- 
ning both polymorphic sites (amino acids 104-177), with internal primers (5 ' -  
3'), followed by digestion with the restriction enzyme HhaI. Separation of the frag- 
CCGGCGCGTGCAG-5'; C Y S I ~ ~ ,  3'-CCTGCACACGCCGG-5'; Cy~158, 3'-CGGTC- 
CTGGGCGCGGACATGGAGGACGT-3 ' and 5 '-GATGGCGCTGAGGCCGCGG- 
242 Mailly et al. 
ments was achieved on 8% polyacrylamide gels (acrylamide:bis, 19:1), run for 3 hr at 
35 mA (constant current) in Tris-borate buffer (0.089 M Tris, 0.089 M boric acid, 
0.002 M EDTA) . 
Statistical Methods 
Statistical tests that gave P < 0.05 were considered significant unless otherwise 
denoted. Analysis of variance was used to compare the 195 heterozygotes included in 
this study with the 29 heterozygotes that were not. Lipids, lipoproteins, and apolipo- 
proteins levels were compared between individuals with discrepant alleles and all other 
heterozygotes from the Rochester Family Heart Study with the same isoforms (or phe- 
notype). Gender- and phenotype-specific multiple regression was used to estimate the 
effects of concomitants (date of assay, age, age2, height, weight, and smoking) in 
those without the discrepant alleles. The levels of the traits were then adjusted for vari- 
ability in concomitants for all of the individuals with the same gender and phenotype 
(both with and without the discrepant alleles) using these regression equations. Per- 
centiles were calculated for the individuals with the discrepant alleles. 
RESULTS 
The distribution of age, measures of body size, lipids, lipoproteins, and apoli- 
poproteins for the heterozygous individuals used in this study are described in Table I 
for the 91 males and 104 females. When the 195 heterozygotes included in this study 
were compared to the 29 heterozygotes not included, there were no differences in the 
mean levels of any traits considered or in the relative frequency of males (data not 
shown). 
Biochemical and molecular analysis of 195 unrelated individuals heterozygous 
for apo E phenotypes by isoprotein typing revealed a number of inconsistent pheno- 
types, as shown in Table 11. Among the 14 inconsistent phenotypes, five were resolved 
by repeat isoprotein typing (two on the redrawn sample), six were resolved by repeat 
AS0 analysis, two were found to be due to sample mislabelling and were resolved by 
resampling of the individuals involved, and one was found to represent a true discrep- 
ancy. Thus, this analysis detected one discrepant allele among the 195 individuals tested, 
TABLE I. Description of 195 Subjects 
Mean (SD) 
Trait Females (n = 104) Males (n = 91) 
Age (years) 41.2 (6.3) 43.5 (6.9) 
Height (cm) 164.8 (6.1) 178.2 (6.1) 
Weight (kg) 68.9 (13.7) 85.4 (12.8) 
Chol (mg/dl) 179.7 (36.8) 190.0 (39.7) 
Trigs (mg/dl) 111.1 (68.9) 163.0 (108.9) 
HDL-C (mg/dl) 50.0 (13.0) 39.6 (10.2) 
Apo A1 (mgldl) 140.1 (18.7) 130.4 (15.8) 
Apo B (mg/dl) 75.6 (15.3) 80.0 (14.4) 
Apo A11 (mg/dl) 34.2 (4.9) 33.5 (4.5) 
Apo CII (mg/dl) 2.0 (0.8) 2.7 (1.0) 
Apo E (mg/dl) 4.4 (1.9) 5.5 (4.3) 
Apo E: Discrepant Alleles 243 
TABLE 11. Apo E Genotype-Phenotype Discrepancies and Partial Resolution Following Retyping of 
Original Samples and Typing of Redraw Samples 
Second Second Third Third 
protein DNA protein DNA 
First First typing - typing - typing - typing - Probable 
protein DNA original original redraw redraw cause of 
Sample typing typing samples samples samples samples Status discrepancy 
288 413 313 413 413 - - Resolved PA“ 
296 312 313 312 312 - - Resolved PA 
330 413 313 413 413 - - Resolved PA 
515 413 414 414 414 - - Resolved SGI’ 
Resolved ?‘ 589 413 313 313 313 - 
1068 312 412 312 312 - - Resolved PA 
Resolved SGI 1096 412 413 413 413 - 
1651 312 412 312 312 Resolved PA 




499 412 313 412 313 412 412 Resolved Sample mix 
1084 312 212 - 212 212 212 Resolved Sample mix 
1612 312 313 312 313 313 313 Resolved SGI 
1622 312 413 312 313 313 313 Resolved SGI 
d 
63 1 312 212 312 212 312 212 Unresolved Mutation 
“PA, poor DNA amplification. 
’SGI, superimposition of glycosylated isofom. 
‘Cause of inconsistency unknown. 
dSample not available. 
an E3 allele at the protein level which was a common E2 (Cysl12, Cys158) at the gene 
level, for an overall frequency of approximately 0.25%. Subject 631 was heterozy- 
gous by isoprotein typing (E3/2) was apparently homozygous by AS0  analysis (E2/2). 
To confirm the genotyping, DNA fragments were amplified spanning the region of the 
apo E gene coding for amino acids 104- 177, the DNA digested with the enzyme HhaI, 
and the size of the resulting fragments analysed by polyacrylamide gel electrophore- 
sis. The pattern of fragments seen was as expected for their AS0 genotype. DNA and 
plasma samples were available for analysis for family members of the individual car- 
rying a discrepant allele, and the results and pedigree ascertained through household 
1749 are shown in Figure 1. The proband’s mother also showed the same discrepancy, 
having an allele which behaved as an E3 allele on isoelectric focusing but appeared as 
an E2 allele by AS0 typing, but neither of the children of the proband inherited the 
discrepant allele. 
Description of Subjects With Discrepant Alleles 
A description of the individual and her mother with a discrepant allele is pre- 
sented in Table III. Based on the physical examination data and medical record review, 
subject 631 had fasted, had never smoked, and did not report the use of any medica- 
tions in the 2 months prior to the study. In 1980, she was diagnosed with mitrial 
prolapse at the Mayo Clinic. Otherwise she was considered not to have any other car- 
diovascular disease, was normotensive, and had had four normal ECGs. Her trait lev- 
els, after adjustment for concomitants, placed her above the 95th percentile for HDL-C 
and below the 5th percentile for apolipoprotein B compared to all other females in the 
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ROCHESTER FAMILY HEART STUDY - HOUSEHOLO 1749 
P 3/2 P 4 / 3  




P 2/2 P 3/2 
G 2/2 0 3/2 
1749 P: PHENOTYPE 
G: GENOTYPE 
Fig. 1. Segregation of the apo E protein isofonn and DNA genotypes in individuals ascertained through 
household number 1749. The numbers below the genotypes (631, 677) are the individuals identification 
number, as referred to in the text. 
Rochester Family Heart Study with the E3/2 phenotype. She was close to the 90th 
percentile for plasma levels of both apolipoprotein A1 and apolipoprotein E. 
The mother of this individual (subject 677) had fasted, had never smoked, and 
was overweight. She had been diagnosed 10 years earlier with hypertension and all 
her ECGs had been normal. She reported taking a diuretic, a calcium supplement, a 
potassium supplement, and replacement estrogen in the 2 months prior to the study. 
After adjustment for concomitants, she was above the 98th percentile for triglycerides 
when compared to all other E4/3 females in the Rochester Family Heart Study. She 
was above the 95th percentile for apolipoprotein CIII and above the 90th for both 
apolipoprotein A11 and CII. Only apolipoprotein B was below the 50th percentile. 
DISCUSSION 
A useful approach to the study of quantitative traits associated with risk of com- 
mon disease is to characterize the association between allelic variation at candidate 
gene or random marker loci and quantitative trait levels [Boerwinkle et al., 19861. The 
measured genotype approach has proven to be usefeul for estimating the impact of 
specific alleles on quantitative traits in samples from the general population. This 
approach has demonstrated a significant contribution of allelic variation at the apoli- 
poprotein E locus in determining plasma levels of apo E, apo B, LDL-cholesterol, and 
total cholesterol in a number of populations [Sing and Davignon, 1985; Boenvinkle 
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TABLE In. Description of the Proband and One Relative With Discrepant Alleles (Percentile Compared 
to Other Females of Same Phenotype After Adjustment for Concomitants) 
F’rohand Mother 
Identification No. 63 1 677 
Household 1749 1749 
Trait 
Gender Female Female 
Age (years) 35.7 62.4 
Height (cm) 162.4 161.2 
Weight (kg) 55.4 82.5 
Cholesterol (mg/dl) 149.0 (18.3%) 237.0 (74.2%) 
Triglycerides (mg/dl) 82.0 (43.1%) 405.0 (98.8%) 
HDL-C (mg/dl) 79.0 (96.3%) 49.0 (59.5%) 
Apo A1 (mg/dl) 170.0 (89.9%) 163.0 (86.1%) 
Apo A11 (mg/dl) 41.1 (79.8%) 40.3 (91.3%) 
Apo €3 (mg/dl) 51.0 (3.7%) 84.0 (31.1%) 
Apo CII (mg/dl) 2.3 (51.3%) 4.1 (90.8%) 
Apo CIII (mg/dl) 18.0 (79.8%) 25.5 (95.6%) 
Apo E (mg/dl) 8.1 (89.0%) 5.3 (62.7%) 
and Sing, 1987; Boenvinkle et al., 1987; Davignon et al., 1988; Kaprio et al., 19911. 
Additionally, it has been used to examine the impact of genetic variation at a variety 
of loci coding for genes that are directly involved in lipid metabolism on quantitative 
lipoprotein lipid traits [Sepehrnia et al., 1989bl. The measured genotype approach 
assumes allelic homogeneity. If heterogeneity exists, then the interpretation of the esti- 
mated allelic effects could be biased. The definition of what constitutes similar alleles 
would affect the estimate itself. Variability between subgroups with respect to the fre- 
quency of and variability in discrepant alleles could impact the interpretation of com- 
parison between presumed genotype classes. 
Initially, we identified 14 inconsistencies between phenotype and genotype. Six 
of these were due to technical difficulties with the ASOs used. Poor amplification of 
DNA, which occurs with some samples possibly because of contamination with salt 
during the preparation, resulted in a poor discrimination between the signal seen with 
the CysIl2 probe and the Arg,,, probe. This was resolved on a second amplification 
and by the use of an AS0 with an additional mismatched base which enabled the dif- 
ferent washing conditions used to be more effective. The major source of discrepancy 
for protein typing (four samples) appears to be due to the glycosylation of apo E isoforms. 
The electrophoretic patterns of apolipoprotein E isofoms on IEF gels are a direct result 
of charge variations dependent on both genetic variation at the apolipoprotein E gene 
locus, and posttranslational modification effects which cause a shift in isoform mobil- 
ity [Zannis and Breslow, 19811. This in turn results in the superimposition of glycosylated 
and nonglycosylated forms in heterozygotes. Recently, Snowdon et al. [ 19911 have 
reported that diabetic subjects, which have a 2- to 10-fold increase in protein glycosy- 
lation, show a disparity between the apo E allelic frequencies obtained by protein and 
DNA typing. Therefore, it is likely that differences in the level of glycosylation, deter- 
mined in part by the plasma glucose level, explain some of the inconsistencies. In 
particular, individual 1622, initially E3/2 at the protein level but with an E3/3 geno- 
type, had elevated plasma glucose (97% percentile compared with other E3/2 RFHS 
individuals after adjustment for concomitants). Alternatively, the amount of protein 
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loaded on the gels for these individuals might influence the typing. Another possible 
source of error, not encountered in this study, is that lipoproteins with the apo E4 
protein are known to have a faster metabolic rate, and are cleared rapidly from the 
circulation. This causes a low plasma concentration of the apo E4 isoform which there- 
fore may escape detection. 
It is of interest that of the original 14 inconsistencies between phenotype and geno- 
type, only one involved an individual with a truly discrepant allele. Two could only be 
resolved by obtaining new samples from the participants due to an error in sample 
labeling. This represents a laboratory misidentification rate of approximately 1 % (2 of 
194 if excluding the individual with a true discrepant allele). Of the remaining 11 incon- 
sistencies, 6 samples were incorrect for only the first DNA typing, 4 samples were 
incorrect for only the first protein typing, and one sample was incorrect for both the 
first typings. We estimate the sample error rates to be approximately 3.6% for the 
DNA typing (7 of 192) and 2.6% (5 of 192) for the protein typing. Both of these error 
rates are 2 to 3 times higher than the relative frequency of errors in sample identifica- 
tion and at least 5 times higher than the relative frequency of individuals with discor- 
dant alleles in this study. Based on these data, laboratory errors in typing for apo E 
have the potential to contribute more to bias in measured genotype studies than sample 
identification errors or discordant alelles for apo E heterozygotes . 
Apolipoprotein and lipoprotein levels in the two individuals identified in this study 
as carrying a discordant allele were not indicative of the lipoprotein profile associated 
with Type I11 hyperlipoproteinaemia. This disorder, characterized by hypercholester- 
olaemia, hypertriglyceridaemia, remnant lipoproteins, and the E2/2 phenotype, has 
been the basis of identifying variant apo E alleles in a number of studies. However, 
the discordant allele may be involved in the development of hyperlipidaemia. While 
individual 63 1 had very low lipid levels, characteristic of normolipidemic indi- 
viduals with the E2/2 phenotype, her mother was clearly hypertriglyceridemic. Draw- 
ing a parallel with type 111, it is possible that their apo E genotypes predisposes them 
to this phenotype but that an additional factor, such as obesity, is needed to cause 
hyperlipidemia. Although we have not attempted the further molecular characteriza- 
tion of this mutant allele, the presence of E2-Christchurch in these individuals can be 
ruled out as this mutation would have been revealed by the cleavage pattern with HhaI. 
The results presented here support the assumption of near homogeneity within 
the three heterozygous apo E genotype classes in Caucasian populations, with an esti- 
mated frequency of discrepancies of less than 1%. This is very likely to represent an 
underestimate as neutral amino acid substitutions, which are expected to be more fre- 
quent, were not accounted for by the methodology used. However, the methodologi- 
cal problems outlined above may still be proportionately much more important for the 
misclassification of individuals. We cannot rule out that a discrepant allele could have 
been missed although this is less likely since the inheritance of apo E alleles was checked 
in the families of all the subjects involved in this study. The results are nevertheless 
consistent with the estimate of 2% (two variant alleles among 100 alleles tested) seen 
by Emi et al. [ 19881 in the Caucasian population of Utah. Whether this estimate applies 
to non-Caucasian populations and whether population differences in the frequency of 
apo E variant alleles contributes to differences in estimated allelic effects in some pop- 
ulations, remains to be determined. 
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